Autologous hematopoietic cell transplantation in non-Hodgkin's lymphoma (Q33769671)

29 July 2017

1 reference

title

Autologous hematopoietic cell transplantation in non-Hodgkin's lymphoma (English)

1 reference

29 July 2017

Johnston LJ

1 reference

29 July 2017

Horning SJ

series ordinal

1 reference

29 July 2017

publication date

1 October 1999

1 reference

Hematology / Oncology Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

889-918

1 reference

Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Treatment of lymphoblastic lymphoma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Feasibility of autologous bone marrow transplantation for early consolidation of follicular non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Treatment of mantle-cell lymphomas with the VAD +/- chlorambucil regimen with or without subsequent high-dose therapy and peripheral blood stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Autologous bone marrow transplantation for patients with poor-prognosis lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Lymphoma: monitoring tumor size and signal intensity with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Long-term follow-up of platinum-based lymphoma salvage regimens. The M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. Report of the Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Long-term survival after histologic transformation of low-grade follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970102-7

7 January 2021

10.1016/S0889-8588(05)70102-7

Identifiers

DOI

1 reference

29 July 2017

1 reference